CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
A multi-centre proof of concept study to assess efficacy and safety of endoscopic hemostasis with combined activated Factors IIa, VIIa, IXa and Xa (Seraseal/Fastact ®) in patients with acute gastrointestinal bleeding
DOI 10.1055/s-0033-1347385
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA Ferlitsch, P Salzl, A Püspök, F Wewalka, R Schöfl, H Lenzen, T Lankisch, E Brownstone, C Madl, W Dolak, M Ferlitsch
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe05/2013
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Endoscopic treatment of severe gastrointestinal bleeding can be difficult and high technical expertise is required. A simple and effective method of endoscopic hemostasis would have a significant impact on treatment success. Aim of the study is to assess the efficacy and safety of endoscopic hemostasis with combined activated factors IIa/VIIa/IXa/Xa (Seraseal, Wortham Laboratories, USA). Methods: Patie…
Zitieren
Zitierempfehlung
A Ferlitsch, P Salzl, A Püspök, F Wewalka, R Schöfl, H Lenzen, T Lankisch, E Brownstone, C Madl, W Dolak, M Ferlitsch (2013) A multi-centre proof of concept study to assess efficacy and safety of endoscopic hemostasis with combined activated Factors IIa, VIIa, IXa and Xa (Seraseal/Fastact ®) in patients with acute gastrointestinal bleeding. Zeitschrift für Gastroenterologie (05). https://doi.org/10.1055/s-0033-1347385
Mit CareLit weiterarbeiten